Workflow
百花医药(600721) - 2017 Q3 - 季度财报
BHCBHC(SH:600721)2017-10-25 16:00

Financial Performance - Operating income for the first nine months was CNY 323,468,277.13, down 21.98% year-on-year[6] - Net profit attributable to shareholders decreased by 34.41% to CNY 69,725,070.34 compared to the same period last year[6] - Basic earnings per share were CNY 0.1741, a decrease of 55.64% compared to the previous year[7] - The net profit attributable to the parent company was ¥69.73 million, a decrease of ¥36.58 million or 34.41% compared to the same period last year[15] - Net profit for the third quarter was CNY 25,565,799.34, compared to CNY 240,467,955.30 in the same period last year, reflecting a significant decrease of approximately 89%[26] - Basic earnings per share for the third quarter were CNY 0.0640, down from CNY 0.7971 in the previous year[27] - The company reported a significant reduction in management expenses, which were CNY 10,993,030.60 for the first nine months, compared to CNY 101,534,134.41 in the previous year[25] - The company reported a total loss of CNY 63,062.17 for Q3 2017, compared to a loss of CNY 361,099,959.20 in Q3 2016[30] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,758,317,640.56, a decrease of 0.92% compared to the end of the previous year[6] - The company's current assets decreased to CNY 651,735,656.31 from CNY 707,918,744.86, reflecting a decline of approximately 7.9%[20] - Total liabilities decreased to CNY 390,194,975.25 from CNY 485,518,140.93, a reduction of approximately 19.6%[21] - Total liabilities were CNY 206,460,777.54, down from CNY 270,265,076.51, indicating a reduction of approximately 24%[24] - Non-current assets totaled CNY 2,261,981,964.61, an increase from CNY 2,170,447,084.60, representing a growth of about 4%[24] Cash Flow - Net cash flow from operating activities was CNY 41,178,062.91, an increase of 177.26% compared to the same period last year[6] - Cash flow from operating activities for the first nine months of 2017 was CNY 41,178,062.91, a significant improvement from a negative cash flow of CNY 53,298,208.19 in the same period last year[33] - The net cash flow from investing activities was -¥70.32 million, a decrease of ¥38.23 million compared to the previous year[16] - The company incurred a net cash outflow of CNY 114,014,893.76 from financing activities in Q3 2017[34] - Investment activities resulted in a net cash outflow of CNY 70,318,941.71 for the first nine months of 2017[33] - The net increase in cash and cash equivalents was negative CNY 150,323,915.60, compared to negative CNY 87,884,608.02 last year[36] Shareholder Information - The total number of shareholders at the end of the reporting period was 12,537[10] - The largest shareholder, Xinjiang Production and Construction Corps, held 19.86% of the shares[10] Government Support - The company received government subsidies amounting to CNY 2,945,620.00 during the reporting period[8] Receivables and Investments - Accounts receivable increased to ¥47.90 million, up ¥25.20 million or 110.99% from the previous period, primarily due to sales received via bank acceptance bills[12] - Prepayments rose to ¥30.61 million, an increase of ¥11.89 million or 63.54%, attributed to higher prepayments for demolition compensation and purchase payments[12] - Other receivables increased to ¥3.31 million, up ¥1.16 million or 54.14%, mainly due to increased borrowing for clinical projects from Nanjing Huawai[12] - Available-for-sale financial assets reached ¥6.84 million, a significant increase of ¥5.00 million or 271.74%, due to an investment in a 9.62% stake in Xinjiang Zhongxin Agricultural E-commerce Co., Ltd.[14] - Long-term equity investments totaled ¥17.66 million, an increase of ¥12.82 million or 264.62%, primarily from an investment of ¥32.00 million in a joint venture[14]